The Rb Pathway and Cancer Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|10|7|581-589

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.7, 2009-07, pp. : 581-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-01 ,pp. : 199-220

Bentham Science Publishers

Access to resources Recommend Favorite

Dendrimers in Cancer Therapeutics and Diagnosis

By  

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1097-1109

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into melanoma: targeting the mTOR pathway for therapeutics

By Pópulo Helena   Soares Paula   Lopes José Manuel  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 689-705

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics

By  

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 354-367

Bentham Science Publishers

Access to resources Recommend Favorite

Individualised cancer therapeutics: dream or reality?

By Senzer Neil   Shen Yuqiao   Hill Colin   Nemunaitis John  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1189-1201

Informa Healthcare

Access to resources Recommend Favorite